서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 21 of 21

Issue DateTitle / Author(s) / CitationFileAltmetrics
2012-10
The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
DOI
2016-02
Isolation of middle east respiratory syndrome coronavirus from a patient of the 2015 Korean outbreak
DOI
2016-07
Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy
DOI
2016-09
Viral Load Kinetics of MERS Coronavirus Infection
DOI
2018-02
Early therapeutic drug monitoring of posaconazole oral suspension in patients with hematologic malignancies
DOI
2018-07
The genetic polymorphism UGT1A4*3 is associated with low posaconazole plasma concentrations in hematological malignancy patients receiving the oral suspension
DOI
2019-02
An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus
DOI
2019-10
Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody
DOI
2020-02
Virus isolation from the first patient with SARS-CoV-2 in Korea
DOI
2020-08
Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity
DOI
2021-01
Stereotypic neutralizing V-H antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals
DOI
2021-03
Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody
DOI
2021-07
Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
DOI
2022-02
Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic
DOI
2022-09
Persistent Antibody Responses Up to 18 Months After Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection
DOI
2022-11
Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer
DOI
2023-02
Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naïve individuals
DOI
2023-03
Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19
DOI
2023-04
Different degree of cytokinemia and T-cell activation according to serum IL-6 levels in critical COVID-19
DOI
2023-11
Tracking antigen-specific TCR clonotypes in SARS-CoV-2 infection reveals distinct severity trajectories
DOI
2024-02
Clinical outcomes and immunological features of COVID-19 patients receiving B-cell depletion therapy during the Omicron era
DOI
1